TrialBreast cancer research and treatment2022

Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer.

Mario E Lacouture et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.